Etoposide Injection 20 mg/mL, 50 mL Multiple-Dose Vial (Hikma Pharmaceuticals)

Etoposide Injection is an antineoplastic agent supplied as a sterile, non-pyrogenic solution at a concentration of 20 mg/mL. Each 50 mL multiple-dose vial contains 1000 mg of etoposide for intravenous administration. This product is intended for hospital and clinical use under the direction of a physician.